A prospective observational study using ePRO-based symptom monitoring in patients with gynecologic and breast cancer

A prospective observational study using ePRO-based symptom monitoring in patients with gynecologic and breast cancer - Not Applicable

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000050935

Enrollment

Registered

2023-04-26

Start date

2023-04-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic Cancer, Breast Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Diagnosis of ovarian, cevival, uterine or breast cancer 2.Scheduled to begin systemic anticancer mono- or combination pharmacotherapy (e.g., cytotoxic anticancer agents, molecularly targeted drugs, and immune checkpoint inhibitors) within a month from enrollment 3.Written consent for the study personally obtained from the subject 4.Capable of using smartphone by themselves and/or with the support from family 5.Aged >=18 at informed consent 6.Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) of 0, 1, or 2 at informed consent

Exclusion criteria

Exclusion criteria: 1.Patients receiving cancer treatment for Synchronous cancers 2.Patients with treatment-emergent adverse events that have not resolved to baseline or Grade <= 2 according to CTCAE version 5.0. 3.Deemed otherwise unsuitable for the study by the principal investigator or other investigators

Design outcomes

Primary

Measure	Time frame
Total app usage rate by patients	—

Countries

Japan

Contacts

Public ContactKenichi Harano

National Cancer Center Hospital East Department Of Medical Oncology

kharano@east.ncc.go.jp04-7133-1111

Outcome results